DI GIORGIO, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 1.942
AS - Asia 1.632
SA - Sud America 525
EU - Europa 442
Continente sconosciuto - Info sul continente non disponibili 270
AF - Africa 43
OC - Oceania 1
Totale 4.855
Nazione #
US - Stati Uniti d'America 1.846
SG - Singapore 722
BR - Brasile 414
CN - Cina 255
VN - Vietnam 205
IT - Italia 173
HK - Hong Kong 168
BD - Bangladesh 96
RU - Federazione Russa 69
FR - Francia 68
AR - Argentina 48
KR - Corea 48
CA - Canada 39
GB - Regno Unito 30
IN - India 30
MX - Messico 25
DE - Germania 20
EC - Ecuador 20
IQ - Iraq 19
ID - Indonesia 15
PL - Polonia 14
CO - Colombia 13
ZA - Sudafrica 12
CL - Cile 10
PK - Pakistan 10
AT - Austria 8
UA - Ucraina 8
EG - Egitto 7
NL - Olanda 7
SA - Arabia Saudita 7
SE - Svezia 7
TR - Turchia 7
UZ - Uzbekistan 7
VE - Venezuela 7
ES - Italia 6
ET - Etiopia 6
DZ - Algeria 5
FI - Finlandia 5
GT - Guatemala 5
JM - Giamaica 5
JP - Giappone 5
LT - Lituania 5
MY - Malesia 5
PE - Perù 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
MA - Marocco 4
PH - Filippine 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
IE - Irlanda 3
JO - Giordania 3
NP - Nepal 3
PS - Palestinian Territory 3
TN - Tunisia 3
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
EE - Estonia 2
HN - Honduras 2
IL - Israele 2
NI - Nicaragua 2
PR - Porto Rico 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BF - Burkina Faso 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
LB - Libano 1
MM - Myanmar 1
MN - Mongolia 1
MV - Maldive 1
PT - Portogallo 1
SV - El Salvador 1
TG - Togo 1
TW - Taiwan 1
VI - Stati Uniti Isole Vergini 1
Totale 4.585
Città #
Ashburn 247
Council Bluffs 246
Singapore 240
San Jose 204
Hong Kong 166
Dallas 115
Beijing 93
Ho Chi Minh City 75
Los Angeles 65
Lauterbourg 59
São Paulo 54
Hanoi 49
Hefei 48
Seoul 48
New York 35
Buffalo 33
Santa Clara 32
Boardman 31
Redondo Beach 29
The Dalles 26
Milan 25
Phoenix 21
Chicago 18
North Bergen 18
Houston 17
Rio de Janeiro 16
Rome 16
Brooklyn 13
Warsaw 13
Naples 12
Richmond Hill 12
Atlanta 11
Charlotte 9
Curitiba 9
Baghdad 8
Belo Horizonte 8
Boston 8
Chennai 8
Orem 8
Da Nang 7
Denver 7
Frankfurt am Main 7
Miami 7
Philadelphia 7
Seattle 7
Thái Bình 7
Amsterdam 6
Cairo 6
Dhaka 6
Haiphong 6
Hải Dương 6
Manaus 6
Porto Alegre 6
San Francisco 6
Xi'an 6
Addis Ababa 5
Brasília 5
Catania 5
Guayaquil 5
Jacksonville 5
Johannesburg 5
Joinville 5
Kansas City 5
Lahore 5
Lima 5
Newark 5
Riyadh 5
Tashkent 5
Thái Nguyên 5
Tokyo 5
Turin 5
Baku 4
Bari 4
Biên Hòa 4
Bogotá 4
Bologna 4
Buenos Aires 4
Cali 4
Campinas 4
Des Moines 4
Fayetteville 4
Guatemala City 4
Mexico City 4
Montreal 4
Poplar 4
Salvador 4
Stockholm 4
Suzhou 4
Udine 4
Wichita 4
Acireale 3
Amman 3
Austin 3
Belluno 3
Bengaluru 3
Cape Town 3
Caxias do Sul 3
Charleston 3
City of London 3
Columbus 3
Totale 2.434
Nome #
Baveno VIII - Advancing Consensus in Portal Hypertension 143
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP 121
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia 118
Percutaneous management of chronic total occlusion of the portal vein: a retrospective analysis of technical aspects and outcomes 89
Gene Therapy in Patients with the Crigler-Najjar Syndrome 88
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 88
Italian children seem to be spared from the mysterious severe acute hepatitis outbreak: A report by SIGENP Acute Hepatitis Group 82
Cardiologic study of 10 patients with Duchenne muscular dystrophy(DMD): personal experience 82
Foreign Body Ingestion in Children: A 16-year Experience 80
Analysis of quality of life, hepatic biochemical markers, and sleep in patients with progressive familial intrahepatic cholestasis who had a pruritus response with odevixibat treatment 79
A Pediatric Emergency Department Protocol to Avoid Intrahospital Spread of SARS-CoV-2 during the Outbreak in Bergamo, Italy 78
Breakthroughs and challenges in the management of pediatric viral hepatitis 78
Cutting edge issues in juvenile sclerosing cholangitis 76
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review 76
ABO Incompatible Liver Transplantation in Children: A 20 Year Experience from Centres in the TransplantChild European Reference Network 74
Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasis 73
Early steroids after pediatric liver transplantation protect against T-cell-mediated rejection: Results from the ChilSFree study 71
A child with congenital heart disease and situs viscerum inversus 71
COVID-19 in Children With Liver Disease 71
AUTOIMMUNE ACUTE LIVER FAILURE IN CHILDREN: CLINICAL CLUES AND A NEW DIAGNOSTIC SCORE 70
Acute Liver Failure in Children: Is It Time to Revise the Diagnostic Criteria? 69
Biliary features in liver histology of children with autoimmune liver disease 68
Cold Ischemia Time and Graft Fibrosis Are Associated with Autoantibodies after Pediatric Liver Transplantation: A Retrospective Cohort Study of the European Reference Network TransplantChild 68
Diagnosing Acute Cellular Rejection after Paediatric Liver Transplantation—Is There Room for Interleukin Profiles? 68
Diagnosing Spontaneous Bacterial Peritonitis in Children: Tap-in for Higher Scores 68
Disease burden and management of Crigler-Najjar syndrome: Report of a world registry 67
Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency 66
Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome 64
Paediatric porto-sinusoidal vascular disease: Two different clinical phenotypes with subtle histological differences 63
EXTRA-HEPATIC PORTAL VEIN OBSTRUCTION IN CHILDREN: A MULTICENTRE NATIONAL STUDY 63
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis 62
Outcome of Very Early Onset Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis: A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN 61
Cytomegalovirus-RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof-of-Concept Study 60
Scurvy: A disease of anesthetic interest? Scurvy and anesthesia 59
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 59
Portal Hypertension in Children 59
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 58
Outcome of Children with Transjugular Intrahepatic Portosystemic Shunt: A Meta-Analysis of Individual Patient Data 58
Diagnostic Yield of an Algorithm for Neonatal and Infantile Cholestasis Integrating Next-Generation Sequencing 57
Use of oral vancomycin in children with autoimmune liver disease: A single centre experience 57
Identifying the Aetiology of Acute Liver Failure Is Crucial to Impact Positively on Outcome 57
Patterns of Presentation of SARS-CoV-2 Infection in Children. Experience at the Italian Epicentre of the Pandemic 56
Long-term Outcome of Asymptomatic Patients with Graft Fibrosis in Protocol Biopsies after Pediatric Liver Transplantation 56
Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome 56
Munchausen syndrome by proxy 56
ODEVIXIBAT TREATMENT IN PATIENTS WITH RECURRENT EPISODIC CHOLESTASIS AND BIALLELIC MUTATIONS IN ATP8B1: A RETROSPECTIVE CASE SERIES 55
Frailty in children with chronic liver disease: Growing evidence for an underexplored topic 55
Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: A multicentre national study 54
The frequency of rare and monogenic diseases in pediatric organ transplant recipients in Italy 54
Septic arthritis in infancy with a good outcome: A study of five patients 53
Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement 52
Distinctive Clinical Features of Portal Hypertension in Children with Portal Vein Thrombosis Following Liver Transplantation 52
Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak on Pediatric Liver Transplant Recipients in Lombardy, Northern Italy 51
Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel 51
Successful management of acute liver failure in Italian children: A 16-year experience at a referral centre for paediatric liver transplantation 51
Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years 50
Adeno-associated virus vector mediated gene therapy for Crigler Najjar syndrome: preliminary report of safety and efficacy from the CareCN clinical trial 50
Reply to comment: Etiology of non-cirrhotic portal vein thrombosis in children: Few or many causes?  50
Melorheostosis: case report with 20-year follow-up 50
Health status of children with chronic liver disease during the SARS-CoV-2-outbreak: results from a multicentre study' 49
Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy 49
Interobserver Agreement on Endoscopic Classification of Oesophageal Varices in Children 49
Transplant-free Survival in Chronic Liver Disease Presenting as Acute Liver Failure in Childhood 48
Feasibility and Efficacy of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Children 48
Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP 46
Fulminant Hepatic Failure of Autoimmune Aetiology in Children 46
Long-term survival in a child with arthrogryposis multiplex congenita and spinal muscular atrophy 45
Variability in the management of portal hypertension across European countries: A survey-study by ESPGHAN Portal Hypertension Special Interest Group 43
Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children 43
Longitudinal Immune Phenotype Assessment and Serological Outcome in Foreign-born Children With Chronic Hepatitis B 42
Long-term Outcome of Transjugular Intrahepatic Portosystemic Shunt in Children With Portal Hypertension 42
Odevixibat for Episodic Intrahepatic Cholestasis due to Biallelic Mutations in ATP8B1: A Case Series 41
Diagnosis and management of sclerosing cholangitis and inflammatory bowel disease in children: A survey by SIGENP 35
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 26
Portal hypertension 25
Clinical Course and Outcomes of Paediatric Chronic Hepatitis B: Insights From a Multicenter Longitudinal Cohort of 248 Patients 24
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 23
Intensive care management of children with liver disease 22
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 20
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 20
Early predictors of pruritus response in children with PFIC treated with odevixibat 17
Reply to: “Managing PFIC 7 with odevixibat: Alleviation of pruritus and biochemical response” 17
Hypertransaminasemia in hospitalized children: Insights from a National Multicenter Study by the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition 17
The Italian biliary atresia registry: Insights and lessons from the retrospective analysis of a 10‐year period cohort 13
Beyond consensus: Identifying divergences in the care of children with portal hypertension 10
Proceedings of ESPGHAN monothematic conference 2024 (II): Management of portal hypertension in children and adolescents 10
Proceedings of ESPGHAN monothematic conference 2024 (I): Aetiology, diagnosis and complications of portal hypertension in children and adolescents 9
Optimized Cytomegalovirus-DNA Threshold for Preemptive Therapy in Pediatric Liver Transplant Recipients: A Mixed-Effects Model-Based Analysis of Prospective Cohort Data 5
Totale 4.855
Categoria #
all - tutte 16.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.017 0 0 0 0 143 30 109 28 86 97 197 327
2025/20262.651 136 380 349 466 289 139 168 114 103 130 223 154
2026/20271.187 112 171 344 531 29 0 0 0 0 0 0 0
Totale 4.855